Treatment of pharmaceutical wastewater by a sequential KMnO4/CoFe2O4-mediated catalytic ozonation process

Abstract

Pharmaceutical compounds, which are of utmost concern, have found their way into natural water bodies, causing numerous problems for both human health and ecosystems. In this study, an integrated system including potassium permanganate (PM) pre-oxidation, followed by a heterogeneous catalytic ozonation process (HCOP) using CoFe2O4 magnetic nanoparticles (CF MNPs), and an activated sludge-based biological treatment (BT) was employed for the first time to treat pharmaceutical wastewater (PWW). In this regard, the effluent from PM pre-oxidation process was used as a batch for the HCOP, and the effluent was used as a batch for the BT process. The results showed that PM pre-treatment of PWW (PM dose = 1264 mg/L and pH = 8.0) reduced the COD content of the PWW from 900 ± 50 to 443 ± 10 mg/L within 120 min of reaction time. The application of HCOP for further treatment of PWW dramatically enhanced COD and TOC removal compared with the single ozonation process (SOP). Under optimum conditions (pH = 10, O3 = 4.0 mg/L, and CF MNPs = 1000 mg/L), HCOP successfully reduced the COD and TOC contents of PWW by 37 % and 46.1 %, respectively, after 120 min of treatment. The consecutive combination of PM pre-treatment followed by HCOP exhibited good potential and reduced COD by over 69 %, resulting in a residual COD of less than 280 mg/L. A biodegradability ratio of over 81 % and residual COD of 54 mg/L for the PWW treated by the PM/HCOP/BT integrated system indicated that biodegradability was enhanced, and a high fraction of refractory organic compounds was effectively removed. In conclusion, the PM/HCOP/BT integrated system is an efficient, synergistic, and easy-to-operate technique for enhancing the biodegradability of PWW.